.png)
SummaryGermany does not divide medicines into "OTC" and "Rx". It uses three legally defined dispensing categories: verschreibungspflichtig (prescription-only), apothekenpflichtig (pharmacy-only, no prescription required) and freiverkäuflich (general sale outside pharmacies). What English-speaking teams call OTC normally covers the second and third categories together, which is why German product data so often fails to line up with an international product master.
That mismatch is not a translation problem. Dispensing status in Germany determines who may sell the product, whether the price is regulated or free, whether statutory health insurance pays for it, and what a manufacturer is allowed to say about it in public. Get the category wrong in your data and four downstream decisions go wrong with it.
This article sets out the three categories and their legal basis, how a substance moves between them, what the reimbursement consequence actually is, which data fields carry the status, and why the distinction has direct commercial weight.
German medicines law works from a default of pharmacy exclusivity and then carves exceptions out of it. Section 43 of the Arzneimittelgesetz (AMG) states the rule: medicines that have not been released for distribution outside pharmacies by Section 44 AMG or by an ordinance under Section 45(1) AMG may be supplied to the end consumer commercially only in pharmacies. Everything else follows from that.
The practical consequence for anyone building a product master: a single Boolean "OTC yes or no" flag cannot represent German reality. A German data record needs at least two independent attributes, prescription status and pharmacy status, because a product can be non-prescription and still pharmacy-only.
In German usage, OTC is a commercial term, not a legal one. It refers to any medicine a person can obtain without a prescription, which spans both apothekenpflichtig and freiverkäuflich products. The German legal term that maps most closely is nicht verschreibungspflichtig, meaning not subject to prescription.
Two errors follow from the confusion and both are common. The first is assuming that OTC means available in retail, which is wrong for the large apothekenpflichtig segment. The second is assuming that OTC means the same regulatory treatment as a US OTC monograph product, which it does not, because German non-prescription medicines still hold a full marketing authorisation and a Summary of Product Characteristics.
| Attribute | Verschreibungspflichtig (Rx) | Apothekenpflichtig (non-Rx) | Freiverkäuflich |
|---|---|---|---|
| Prescription required | Yes | No | No |
| Point of sale | Pharmacy only | Pharmacy only | Pharmacy, drugstore, general retail |
| Primary legal basis | Section 48 AMG plus AMVV | Section 43 AMG | Section 44 AMG and the associated ordinance |
| Price setting | Regulated by the Arzneimittelpreisverordnung | Free | Free |
| Advertising to the public | Prohibited under Section 10 HWG | Permitted, subject to HWG rules | Permitted, subject to HWG rules |
| Statutory health insurance | Generally reimbursed | Generally excluded, defined exceptions apply | Generally excluded, defined exceptions apply |
| Counted as "OTC" internationally | No | Yes | Yes |
Section 48 AMG is the enabling provision. It makes a medicine prescription-only if it contains a substance listed in an ordinance issued under that section, or if it contains substances whose effects are not generally known in medical science. The ordinance itself is the Arzneimittelverschreibungsverordnung (AMVV), whose Annex 1 lists the substances concerned, frequently with qualifying conditions on indication, strength, pack size or route of administration.
Two features of the AMVV catch people out. First, prescription status attaches primarily to the active substance under stated conditions, not to the finished product, so the same substance can be prescription-only above a certain strength and non-prescription below it. Second, the ordinance is issued by the Federal Ministry of Health in agreement with the Federal Ministry for Economic Affairs and requires the consent of the Bundesrat. That is why status changes arrive in batches on fixed dates rather than continuously.
Newly authorised active substances are, as a rule, placed under prescription control first. The movement in the other direction is the switch.
An OTC switch in Germany is a regulatory procedure with a defined sequence, not a company decision. It normally begins with an application from the marketing authorisation holder to the Federal Institute for Drugs and Medical Devices (BfArM). After formal and substantive review, the application goes to the Sachverständigen-Ausschuss für Verschreibungspflicht, the expert committee on prescription status, which meets twice a year and issues a recommendation.
The recommendation goes to the Federal Ministry of Health. If the ministry follows it, a draft amendment to the AMVV is prepared, put out for comment and submitted to the Bundesrat. The change takes effect only when that amendment enters into force. Three points matter for anyone tracking status data:
The consequence for data is that dispensing status is a moving attribute with an effective date. A product master that treats it as static will be wrong twice a year, and wrong in the direction that matters for pricing and reimbursement.
The rule is set by Section 34(1) of the Social Code Book V. Non-prescription medicines are excluded from supply at the expense of statutory health insurance. Since Rx status and reimbursability are so closely coupled, a switch is also a reimbursement event.
The exclusion is not absolute. The defined exceptions currently are:
Annex I is not a blanket clearance of a product. Each entry ties a substance or substance group to a defined indication, and prescription outside that indication is not covered. Anyone modelling German reimbursement therefore needs the indication condition alongside the entry, not just the substance name.
At article level, a German medicinal product record is built around a small set of fields that recur across every commercial and clinical workflow:
| Field | What it carries | Why it matters |
|---|---|---|
| PZN | Eight-digit Pharmazentralnummer identifying one package of one product | The key for ordering, billing and stock. It is package-specific, not product-specific |
| Dispensing status | Prescription-only, pharmacy-only or general sale, with effective date | Drives sales channel, price regime, advertising and reimbursement |
| ATC code | WHO Anatomical Therapeutic Chemical classification of the active substance | The only reliable cross-brand and cross-border grouping key |
| Pack size and strength | Number of units, strength, dosage form, plus the German N1, N2, N3 pack size category where applicable | Determines therapeutic comparability and often the prescription threshold itself |
| Price | Manufacturer price, pharmacy purchase price and pharmacy retail price | Regulated for Rx, free for non-prescription, so the meaning of the field differs by category |
Notice what the table implies. The same field name means different things depending on dispensing status. A retail price on a prescription product is the output of a regulated calculation. A retail price on a freiverkäuflich product is a commercial decision by whoever is selling it, which is why competing sources can legitimately disagree about it.
"What we want is to be able to click through the databases and not have to go to different sites to gather the information together." Pharmacist at a military hospital, translated from German
Three separate business systems hang off a single status field.
Pricing. For prescription-only medicines the Arzneimittelpreisverordnung sets wholesale and pharmacy markups, which is what produces a uniform pharmacy retail price nationwide. Section 1 of that ordinance explicitly excludes the margins and prices of non-prescription medicines, so pricing for the OTC segment is free and genuinely competitive. A switch therefore moves a product from a regulated price to a market price overnight.
Distribution. Prescription and pharmacy-only products reach the consumer only through pharmacies, including mail-order pharmacies operating under the applicable rules. Freiverkäuflich products open up drugstore and general retail channels, and with them an entirely different set of trading partners, listing negotiations and logistics.
Advertising. Section 10(1) of the Heilmittelwerbegesetz (HWG) restricts advertising for prescription-only medicines to physicians, dentists, veterinarians, pharmacists and persons lawfully trading in those medicines. Advertising to the general public is not permitted. Non-prescription medicines may be advertised to the public, within the remaining constraints of the HWG. For a marketing team, a switch is the moment an entire communication channel opens.
These three consequences are why status accuracy is a commercial control, not a data hygiene nicety. A stale status flag can produce an unlawful advertisement, an incorrect price calculation and a rejected reimbursement claim from the same underlying error.
Most teams hit the same wall. Prescription data, non-prescription data, pricing, reimbursement conditions and international equivalents live in separate sources with separate update cycles, and the join between them has to be done by hand. That work scales badly, and it scales worst exactly where the value is, which is the cross-border and cross-layer question.
pharmazie.com was built for that join. It consolidates more than 25 pharmaceutical databases behind a single search covering over 50,000 German products and more than 120,000 international products across 50+ countries, with prescription and non-prescription products in the same result set rather than in separate systems. Dispensing status, ATC code, PZN, pack data and price sit on the same record, and the same data is available through REST web services for integration into ERP, warehouse management and MSV3 workflows. For questions that cross the OTC and Rx boundary or cross a national border, that consolidation is the point.
DACON GmbH has maintained pharmaceutical reference data since 1989, exclusively for professional audiences.
This content is intended for healthcare professionals and does not constitute medical advice. Last reviewed: July 2026.
